The Relevance of External Quality Assessment for Molecular Testing for ALK Positive Non-Small Cell Lung Cancer: Results from Two Pilot Rounds Show Room for Optimization-Reference-Cited by-同舟云学术

The Relevance of External Quality Assessment for Molecular Testing for ALK Positive Non-Small Cell Lung Cancer: Results from Two Pilot Rounds Show Room for Optimization

Published:2014-11-11 Issue:11 Volume:9 Page:e112159
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tembuyser Lien,Tack Véronique,Zwaenepoel Karen,Pauwels Patrick,Miller Keith,Bubendorf Lukas,Kerr Keith,Schuuring Ed,Thunnissen Erik,Dequeker Elisabeth M. C.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Global cancer statistics;A Jemal;CA Cancer J Clin,2011

2. Lung cancer biomarkers: present status and future developments;PT Cagle;Arch Pathol Lab Med,2013

3. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;EL Kwak;N Engl J Med,2010

4. Gefitinib in advanced non-small cell lung cancer: does it deserve a second chance?;TE Stinchcombe;Oncologist,2008

5. Erlotinib in previously treated non-small-cell lung cancer;FA Shepherd;N Engl J Med,2005

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemistry of Lung Cancer Biomarkers;Advances in Anatomic Pathology;2024-04-26

2. A Multimodal Biomarker Predicts Dissemination of Bronchial Carcinoid;Cancers;2022-06-30

3. Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer;Lung Cancer;2021-10

4. A novel break site of EML4‐ALK report and a rare PRKAR1A‐ALK report analyzed by different ALK detection platforms in non‐small cell lung cancer patients;Thoracic Cancer;2021-09-06

5. Frequency of Participation in External Quality Assessment Programs Focused on Rare Diseases: Belgian Guidelines for Human Genetics Centers;JMIR Medical Informatics;2021-07-12